Anzeige
Meldung des Tages: Lettland-Defence-Zertifikat! Diese Aktie öffnet die Tür zu bis zu 3 Mio. € Finanzierung

Cellebrite DI Aktie News

Aktie
WKN:  A3D00S ISIN:  IL0011794802 US-Symbol:  CLBT Branche:  Software Land:  Israel
13,16 $
-0,60 $
-4,36%
11,170 € 20.02.26
Depot/Watchlist
Marktkapitalisierung *
3,75 Mrd. €
Streubesitz
3,12%
KGV
-19,32
Index-Zuordnung
-

Cellebrite DI News

11.02.26 - PR Newswire
Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results
Cellebrite Announces Record Fourth-​Quarter and Full-Year 2025 Results PR Newswire
11.02.26 - PR Newswire
Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results
Cellebrite Announces Record Fourth-​Quarter and Full-Year 2025 Results PR Newswire
05.02.26 - PR Newswire
Cellebrite Branchentrend-Bericht 2026: Smartphones mit 97 % die wichtigste Quelle für digitale Beweismittel in Ermittlungen
Cellebrite Branchentrend-​Bericht 2026: Smartphones mit 97 % die wichtigste Quelle für digitale Beweismittel in Ermittlungen PR Newswire
05.02.26 - PR Newswire
Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97%
Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97% PR Newswire
05.02.26 - PR Newswire
Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97%
Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97% PR Newswire
21.01.26 - PR Newswire
Cellebrite veröffentlicht am 11. Februar 2026 die Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2025
Cellebrite veröffentlicht am 11. Februar 2026 die Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2025 PR Newswire
21.01.26 - PR Newswire
Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
Cellebrite to Report Fourth-​Quarter and Fiscal Year 2025 Financial Results on February 11, 2026 PR Newswire
21.01.26 - PR Newswire
Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
Cellebrite to Report Fourth-​Quarter and Fiscal Year 2025 Financial Results on February 11, 2026 PR Newswire
02.12.25 - GlobeNewswire
Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
The addition of Corellium’s leading virtualization technology to the Cellebrite platform delivers unmatched capabilities that transcend digital forensics, investigations, analytics and ...
30.10.25 - GlobeNewswire
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer
Appointment Builds on the Momentum Behind Cellebrite’s Preeminent Digital Investigation Portfolio and Market-​Leading Investigative Solutions to Accelerate Justice
28.10.25 - GlobeNewswire
Actor, Host, Artist and Anti-Human Trafficking Advocate Terry Crews to Headline Cellebrite C2C User Summit 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative and Intelligence solutions ...
15.10.25 - GlobeNewswire
Cellebrite erweitert Marktpräsenz mit Innovationen in den Bereichen agentenbasierte KI, Cloud und Gerätevirtualisierung für die Herbstversion 2025
TYSONS CORNER, Virginia, und PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), ein weltweit führender Anbieter von digitalen ...
15.10.25 - GlobeNewswire
Cellebrite Expands Market Reach with Innovations in Agentic AI, Cloud and Device Virtualization for the Company’s Autumn 2025 Release
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the ...
04.09.25 - wallstreetONLINE Redaktion
Favoritenliste: JPMorgan kürt neue Favoriten: Diese Aktien haben im September großes Potenzial
JPMorgan hat seine Favoritenliste für September neu aufgestellt. Mit dabei sind PTC Therapeutics, Armstrong World Industries und McCormick. Die Hintergründe. Die Analysten von ...
08.07.25 - GlobeNewswire
Cellebrite Names David Barter Chief Financial Officer
CFO Dana Gerner to Retire
24.06.25 - GlobeNewswire
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private ...
05.06.25 - GlobeNewswire
Cellebrite to Acquire Corellium
Combination Delivers Unmatched Innovation in Arm-based Vulnerability and Malware Research, Smart Device DevSecOps and Mobile Pen Testing
06.05.25 - GlobeNewswire
Cellebrite stellt die Version für das Frühjahr 2025 vor, um weltweite Untersuchungen zu beschleunigen
KI und Cloud als strategische Grundlagen für die nächste Generation der digitalen Untersuchungsplattform
06.05.25 - GlobeNewswire
Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations
AI and Cloud as Strategic Foundations for the Next Era of its Digital Investigation Platform

Newssuche

Videos

newspaper
18.02.26 -2,76%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
DiagnosTear Technologies Inc
0,268 €
+5,51%
DiagnosTear Technologies Inc Chart
TeaRx™ erobert Großbritannien im Sturm?!
Mehr zur Aktie »